Published in Hepatitis Weekly, September 23rd, 2002
Welch succeeds Dr. David Barry, founder and former chief executive officer, who died in January 2002.
Welch has over 23 years of pharmaceutical experience with specialty pharmaceutical companies as well as with leading global pharmaceutical companies. From 2000 to the present, Welch was president, biopharmaceuticals, at Elan Corp. where he was responsible for the worldwide activities of Elan's largest business unit, including the U.S. commercial operation, the international subsidiaries, the R&D function, and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.